A dwindling COVID-19 vaccine market is not stopping Arcturus Therapeutics from pressing ahead with its own mRNA candidate, as the biotech touts new early data indicating its shot lights up the immune ...
Some recent data suggest that, for now, COVID-19 may be a year-round problem, driven more by human behavior and immunity levels than weather patterns. Credit: Unsplash / Maxime The pandemic may no ...
KING OF PRUSSIA, Pa. & SAN DIEGO--(BUSINESS WIRE)-- Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and Arcturus Therapeutics (Nasdaq: ARCT) today announced the results of a follow-up analysis ...
SAN DIEGO--(BUSINESS WIRE)--Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Visit San Antonio's CEO is ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min More than four years after Covid ...
The devastating effects of the Covid-19 pandemic suffered by our economies compels us to swiftly formulate innovative solutions that will manage and minimise the negative effects of the virus on our ...
The seminar, hosted under the theme Developing Afrocentric solutions and forging partnership in response to COVID 19, was undertaken with the goal of mobilising South African and Zambian business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results